01 June 2006
An assessment of downward trends in neurodevelopmental disorders in the United States following removal of thimerosal from childhood vaccines.
David A. Geier, Mark R. GeierMed Sci Monit 2006; 12(6): CR231-239 :: ID: 451248
Abstract
Background: The US is in the midst of an epidemic of neurodevelopmentaldisorders (NDs). Thimerosal is an ethylmercury-containing compound added to some childhood vaccines.Several previous epidemiological studies conducted in the US have associated Thimerosal-containing vaccine(TCV) administration with NDs. Material/Methods: An ecological study was undertaken to evaluate NDs reportedto the Vaccine Adverse Event Reporting System (VAERS) from 1991 through 2004 by date of receipt and bydate of vaccine administration. The NDs examined included autism, mental retardation, and speech disorders.Statistical trend analysis was employed to evaluate the effects of removal of Thimerosal on the proportionof NDs reported to VAERS. Results: There was a peak in the proportion of ND reports received by VAERSin 2001-2002 and in the proportion of ND reports by date of vaccine administration in 1998. There weresignificant reductions in the proportion of NDs reported to VAERS as Thimerosal was begun to be removedfrom childhood vaccines in the US from mid-1999 onwards. Conclusions: The present study provides thefirst epidemiological evidence showing that as Thimerosal was removed from childhood vaccines, the numberof NDs has decreased in the US. The analysis techniques utilized attempted to minimize chance or bias/confounding.Additional research should be conducted to further evaluate the relationship between TCVs and NDs. Thisis especially true because the handling of vaccine safety data from the National Immunization Programof the CDC has been called into question by the Institute of Medicine of the National Academy of Sciencesin 2005.
Keywords: Child Development Disorders, Pervasive - epidemiology, Child, Preschool, Preservatives, Pharmaceutical - toxicity, Thimerosal - toxicity, United States, Vaccines - adverse effects
Editorial
01 January 2026 : Editorial
Editorial: Increasing Awareness of Lung Cancer in Non-Smokers and Never-Smokers Challenges Current Approaches to Prevention and ScreeningDOI: 10.12659/MSM.952454
Med Sci Monit 2026; 32:e952454
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






